BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1693856)

  • 1. Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes.
    Harrison RK; Stein RL
    Biochemistry; 1990 Apr; 29(16):3813-6. PubMed ID: 1693856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of peptidyl-prolyl cis/trans isomerase activity by substrate analog structures: thioxo tetrapeptide-4-nitroanilides.
    Schutkowski M; Wöllner S; Fischer G
    Biochemistry; 1995 Oct; 34(40):13016-26. PubMed ID: 7548060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel peptidyl-prolyl cis/trans isomerase from Escherichia coli.
    Rahfeld JU; Schierhorn A; Mann K; Fischer G
    FEBS Lett; 1994 Apr; 343(1):65-9. PubMed ID: 8163020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic studies of peptidyl prolyl cis-trans isomerase: evidence for catalysis by distortion.
    Harrison RK; Stein RL
    Biochemistry; 1990 Feb; 29(7):1684-9. PubMed ID: 2184885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin.
    Maki N; Sekiguchi F; Nishimaki J; Miwa K; Hayano T; Takahashi N; Suzuki M
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5440-3. PubMed ID: 1695378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.
    Harding MW; Galat A; Uehling DE; Schreiber SL
    Nature; 1989 Oct; 341(6244):758-60. PubMed ID: 2477715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay.
    Kofron JL; Kuzmic P; Kishore V; Colón-Bonilla E; Rich DH
    Biochemistry; 1991 Jun; 30(25):6127-34. PubMed ID: 2059621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidyl-prolyl cis-trans isomerase activity as studied by dynamic proton NMR spectroscopy.
    Hübner D; Drakenberg T; Forsén S; Fischer G
    FEBS Lett; 1991 Jun; 284(1):79-81. PubMed ID: 2060630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mip protein of Legionella pneumophila exhibits peptidyl-prolyl-cis/trans isomerase (PPlase) activity.
    Fischer G; Bang H; Ludwig B; Mann K; Hacker J
    Mol Microbiol; 1992 May; 6(10):1375-83. PubMed ID: 1379319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK-506 binding protein from Tolypocladium inflatum: resistance of FKBP/FK-506 complex against proteolysis.
    Lee C; Hoffmann K; Zocher R
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1282-7. PubMed ID: 1371677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent inhibition of peptidylprolyl cis-trans-isomerases by FK506 is probably due to cis-trans isomerization of the inhibitor's imide bond.
    Zarnt T; Lang K; Burtscher H; Fischer G
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):159-64. PubMed ID: 7529995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis of cyclophilin-catalyzed prolyl cis/trans isomerization by dynamic NMR spectroscopy.
    Kern D; Kern G; Scherer G; Fischer G; Drakenberg T
    Biochemistry; 1995 Oct; 34(41):13594-602. PubMed ID: 7577948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.
    Siekierka JJ; Hung SH; Poe M; Lin CS; Sigal NH
    Nature; 1989 Oct; 341(6244):755-7. PubMed ID: 2477714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPIase catalysis by human FK506-binding protein proceeds through a conformational twist mechanism.
    Park ST; Aldape RA; Futer O; DeCenzo MT; Livingston DJ
    J Biol Chem; 1992 Feb; 267(5):3316-24. PubMed ID: 1371117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamics of cyclophilin catalyzed peptidyl-prolyl isomerization by NMR spectroscopy.
    Videen JS; Stamnes MA; Hsu VL; Goodman M
    Biopolymers; 1994 Feb; 34(2):171-5. PubMed ID: 8142586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure implies that cyclophilin predominantly catalyzes the trans to cis isomerization.
    Zhao Y; Ke H
    Biochemistry; 1996 Jun; 35(23):7356-61. PubMed ID: 8652511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate.
    Rosen MK; Standaert RF; Galat A; Nakatsuka M; Schreiber SL
    Science; 1990 May; 248(4957):863-6. PubMed ID: 1693013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans isomerase.
    Siekierka JJ; Wiederrecht G; Greulich H; Boulton D; Hung SH; Cryan J; Hodges PJ; Sigal NH
    J Biol Chem; 1990 Dec; 265(34):21011-5. PubMed ID: 1701173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal cyclophilin-homologous domain of a 150-kilodalton tumor recognition molecule exhibits both peptidylprolyl cis-trans-isomerase and chaperone activities.
    Rinfret A; Collins C; Ménard R; Anderson SK
    Biochemistry; 1994 Feb; 33(7):1668-73. PubMed ID: 7906541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH titration of the histidine residues of cyclophilin and FK506 binding protein in the absence and presence of immunosuppressant ligands.
    Yu L; Fesik SW
    Biochim Biophys Acta; 1994 Nov; 1209(1):24-32. PubMed ID: 7524680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.